InvestorsHub Logo
icon url

Realcool11

08/29/21 6:19 AM

#352686 RE: shadolane #352684

At least there were no adverse effects compared to placebo. That would have been a doozie. It was a long shot to expect V would prevent infection anyhow. It’s more important to see if it mitigates symptoms and outcomes. That remains to be seen but these results in P1 will taper expectations.
icon url

Invest83838

08/29/21 7:53 AM

#352695 RE: shadolane #352684

Agree shadolane

we will be lucky if AMRN stays in the 5s

until the next "news" (i.e. build up and let down),

whenever that will be